Many lung cancer patients receive meds that prolong QTc interval

(HealthDay)—A considerable proportion of patients with lung cancer are prescribed medications that prolong the corrected QT (QTc) interval, limiting their eligibility for clinical trials, according to

Updated on: December 22,2023

Many lung cancer patients receive meds that prolong QTc interval

(HealthDay)—A considerable proportion of patients with lung cancer are prescribed medications that prolong the corrected QT (QTc) interval, limiting their eligibility for clinical trials, according to

Updated on:December 22,2023

Why some cancers affect only young women

byUniversity of GenevaCredit: CC0 Public DomainAmong several forms of pancreatic cancer, one of them specifically affects women, often young. How is this possible, even though the pancreas is an

Updated on: December 18,2023

Why some cancers affect only young women

byUniversity of GenevaCredit: CC0 Public DomainAmong several forms of pancreatic cancer, one of them specifically affects women, often young. How is this possible, even though the pancreas is an

Updated on:December 18,2023

Allogeneic HCT after primary induction failure beneficial in leukemia

by Elana GotkineFor patients with acute myeloid leukemia (AML), immediate allogeneic hematopoietic stem cell transplantation (HCT) after primary induction failure (PIF) offers long-term survival benef

Updated on: December 26,2023

Allogeneic HCT after primary induction failure beneficial in leukemia

by Elana GotkineFor patients with acute myeloid leukemia (AML), immediate allogeneic hematopoietic stem cell transplantation (HCT) after primary induction failure (PIF) offers long-term survival benef

Updated on:December 26,2023

AI-assisted breast-cancer screening may reduce unnecessary testing

byWashington University School of MedicineOn average, radiologists find one case of cancer (bottom images) in every 200 mammograms they evaluate. The top images show no cancer. In a recent study

Updated on: April 27,2024

AI-assisted breast-cancer screening may reduce unnecessary testing

byWashington University School of MedicineOn average, radiologists find one case of cancer (bottom images) in every 200 mammograms they evaluate. The top images show no cancer. In a recent study

Updated on:April 27,2024

Australian scientists closer to finding new lung cancer treatments

byAustralian National UniversityAssociate Professor Marian Burr. Credit: Jamie Kidston/ANUScientists from The Australian National University (ANU) and the Peter MacCallum Cancer Centre have disc

Updated on: December 19,2023

Australian scientists closer to finding new lung cancer treatments

byAustralian National UniversityAssociate Professor Marian Burr. Credit: Jamie Kidston/ANUScientists from The Australian National University (ANU) and the Peter MacCallum Cancer Centre have disc

Updated on:December 19,2023

Strategy could remove metastatic traits and drug resistance from lung cancer cells

byThe Korea Advanced Institute of Science and Technology (KAIST)Figure 1. Construction of the mathematical model of the regulatory network to represent the EMT phenotype based on the interaction

Updated on: December 19,2023

Strategy could remove metastatic traits and drug resistance from lung cancer cells

byThe Korea Advanced Institute of Science and Technology (KAIST)Figure 1. Construction of the mathematical model of the regulatory network to represent the EMT phenotype based on the interaction

Updated on:December 19,2023

Survey: Most women unaware of the signs of an aggressive form of breast cancer

by Ohio State University Comprehensive Cancer CenterDr. Ko Un Park consults with a patient at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Sol

Updated on: December 20,2023

Survey: Most women unaware of the signs of an aggressive form of breast cancer

by Ohio State University Comprehensive Cancer CenterDr. Ko Un Park consults with a patient at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Sol

Updated on:December 20,2023

Team learns how to predict triple negative breast cancer recurrence

byIndiana University School of MedicineCredit: Anna CarreraIndiana University School of Medicine researchers have discovered how to predict whether triple negative breast cancer will recur, and

Updated on: December 22,2023

Team learns how to predict triple negative breast cancer recurrence

byIndiana University School of MedicineCredit: Anna CarreraIndiana University School of Medicine researchers have discovered how to predict whether triple negative breast cancer will recur, and

Updated on:December 22,2023

Nine common questions about genetic testing for cancer

by Dan Lea,Mayo ClinicCredit: Pixabay/CC0 Public DomainYour genes play a role in nearly all areas of your health. A gene is like an instruction manual for your body that tells your body how to f

Updated on: December 22,2023

Nine common questions about genetic testing for cancer

by Dan Lea,Mayo ClinicCredit: Pixabay/CC0 Public DomainYour genes play a role in nearly all areas of your health. A gene is like an instruction manual for your body that tells your body how to f

Updated on:December 22,2023

Blood Stem Cell Mutations Exacerbate Colon Cancer Growth

byColleen Fleisson August 26, 2023Certaincolon cancersmay experience accelerated growth due to typical age-related alterations in the blood system, said University of Florida C

Updated on: December 19,2023

Blood Stem Cell Mutations Exacerbate Colon Cancer Growth

byColleen Fleisson August 26, 2023Certaincolon cancersmay experience accelerated growth due to typical age-related alterations in the blood system, said University of Florida C

Updated on:December 19,2023

AFM24 Plus Atezolizumab Shows Acceptable Safety, Early Activity in EGFR+ Solid Tumors

January 14, 2023Ryan ScottA doublet comprised of the bispecific innate cell engager AFM24 and atezolizumab had a tolerable safety profile and elicited responses in patients with advanced EGFR-expressi

Updated on: October 15,2023

AFM24 Plus Atezolizumab Shows Acceptable Safety, Early Activity in EGFR+ Solid Tumors

January 14, 2023Ryan ScottA doublet comprised of the bispecific innate cell engager AFM24 and atezolizumab had a tolerable safety profile and elicited responses in patients with advanced EGFR-expressi

Updated on:October 15,2023

Clinical trial reveals new subtypes of advanced pancreatic cancer

by Ontario Institute for Cancer ResearchDrs. Faiyaz Notta and Steven Gallinger in a laboratory. Credit: OICRResearchers at the Ontario Institute for Cancer Research (OICR) and the University Health Ne

Updated on: December 20,2023

Clinical trial reveals new subtypes of advanced pancreatic cancer

by Ontario Institute for Cancer ResearchDrs. Faiyaz Notta and Steven Gallinger in a laboratory. Credit: OICRResearchers at the Ontario Institute for Cancer Research (OICR) and the University Health Ne

Updated on:December 20,2023